Check Point Software Technologies LtdCHKP

Check Point Software Technologies Ltd closed its 2025 financial year with $2.73bn in revenue, $1.06bn in net income, and $1.2bn of operating cash, all filed in its 20-F for the year to 31 December 2025. The company’s balance sheet still reads like a well-funded guardian: $7.81bn in assets against $4.92bn in liabilities, leaving $2.88bn in shareholders’ equity and $1.8bn of cash on hand. Diluted EPS clocked in at $9.62 on 109.9m weighted shares, giving the board plenty of headroom for buybacks or dividends without touching debt.

Check Point’s core is network and cloud security software sold to enterprises that cannot afford a breach on a Monday morning. The company’s latest 6-K (filed 22 July 2026) drops a sprawling sentence about operating across AI, cybersecurity, data, fintech, enterprise software and infrastructure since 2014, but the filing’s real headline is the reminder that shareholders can review the proxy statement on the website-an unusually polite nudge that a key proposal still lacks the votes it needs.

Research and development consumed $456.7m in 2025, while capital expenditure on servers and desks totalled $26.6m, numbers that rarely make the polished brochures but matter when analysts ask where the next margin point comes from. The company’s operating income of $831.1m supports a 30% operating margin, but the R&D bill is growing faster than revenue (up 11% year-on-year in the 20-F), a tension the next earnings cycle will have to explain.

Insider trading filings for June and July 2026 show multiple Rule 10b5-1 plans in use, a compliance ritual that lets executives trade while claiming they followed a pre-set script. The footnotes confirm the optics without changing the substance: Check Point is a cash-generative giant whose biggest risk is not the cyber threat it sells against, but the cost of keeping its own engineers one step ahead of the same attackers it charges to stop.

The company’s most recent cash flow statement shows $1.2bn net cash from operations, enough to fund shareholder returns, R&D and routine capex without strain. The tension is visible in the footnotes: R&D keeps rising, revenue growth is single-digit, and the board’s buyback rhetoric must eventually meet the bill from the income statement. Until then, the balance sheet remains the sturdiest part of the story.

All filings and ownership updates are available on SEC EDGAR under CIK 1015922, and the company’s own website hosts the proxy statement when it’s ready for shareholder scrutiny.